Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
21,19 USD | +1,63 % | +0,43 % | -0,75 % |
16.01. | KENVUE INC. : UBS bleibt neutral | ZM |
16.01. | KENVUE INC. : Barclays gibt neutrale Bewertung ab | ZM |
Kenvue Inc. Gruppe: Beziehungs-Chart
Private Unternehmen, die zur gleichen Gruppe wie KENVUE INC. gehören
Unternehmen | Geschäftsführender Direktor |
---|---|
McNeil AB
McNeil AB Pharmaceuticals: MajorHealth Technology McNeil AB operates within the consumer health care division that develops and manufactures medicines. It specializes in the manufacture of self-care medicines. The firm offers NICORETTE products for the global market. The company was founded in December 2006 and is headquartered in Helsinborg, Sweden. | Joseph David Lodge |
MarketScreener is also available in this country: United States.
Switch edition